Clinical Evidence
Study Three
A preliminary study of Orassist (Gelclair®) in the management of oral mucositis
Berndtson M.
Svensk Sjukhustandlakartidning {Swedish Hospital Dentistry} 2001; 26(3): 17–21.
Study Outline
Ten patients were given Gelclair® to evaluate its effect on their symptoms of oral mucositis.
Results
All reported that the product was acceptable for its taste and consistency, and a palliative soothing effect was noted.
Reporting of side effects
Medical device adverse incidents should be reported to the MHRA. Reporting information can be found at https://yellowcard.mhra.gov.uk/. Any adverse event should also be reported to Pharmacovigilance at Alliance Pharmaceuticals Limited
Tel: 01249 466 966 or email: [email protected]
